V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20224423 | 20084917 | 1.46 | 87.7 | Palliative (P) | 2019-10-22 | 2019-10-23 | Enzalutamide | 02 | N | OCTREOTIDE | 101414628 |
| 20224425 | 20084918 | 1.72 | null | Palliative (P) | 2018-07-11 | 2018-07-11 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100055645 |
| 20224440 | 20084919 | 1.71 | 51.6 | Palliative (P) | 2019-06-01 | 2019-06-07 | Capecitabine + Cisplatin + RT | N | Y | CAPECITABINE + CISPLATIN + RT | 100920029 |
| 20224441 | 20084920 | 1.82 | 75.7 | Curative (C) | 2016-06-09 | 2016-06-09 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100240365 |
| 20224447 | 20084921 | 1.8 | 67.2 | Palliative (P) | 2016-05-17 | 2016-05-18 | Enzalutamide | 02 | N | TRASTUZUMAB | 101077473 |
| 20224451 | 20084922 | 1.52 | 60.5 | Palliative (P) | 2019-05-16 | 2019-06-05 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100611583 |
| 20224452 | 20084923 | 1.7 | 72.4 | null | 2017-01-02 | 2017-01-02 | Enzalutamide | 99 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100260372 |
| 20224457 | 20084924 | 1.54 | 47.1 | Palliative (P) | 2018-11-28 | 2018-11-28 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 101736753 |
| 20224464 | 20084925 | 1.69 | 90.3 | Palliative (P) | null | 2017-01-30 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101270388 |
| 20224469 | 20084926 | 1.51 | 91.1 | null | 2019-11-02 | 2019-11-11 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101561501 |
| 20224470 | 20084927 | 1.65 | 91.45 | Adjuvant (A) | 2014-10-08 | 2014-10-13 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101307163 |
| 20224477 | 20084928 | 1.7 | 70.9 | Palliative (P) | 2019-06-19 | 2019-07-20 | Enzalutamide | null | N | OCTREOTIDE | 101000348 |
| 20224481 | 20084929 | 1.69 | 114.1 | Curative (C) | 2016-05-07 | 2016-05-29 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100728293 |
| 20224482 | 20084930 | 1.72 | null | Palliative (P) | 2018-07-09 | 2018-07-18 | Enzalutamide | 02 | N | TRASTUZUMAB | 101278552 |
| 20224496 | 20084931 | 1.77 | 77.2 | null | 2017-12-14 | 2017-12-29 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN + RT | 100387187 |
| 20224500 | 20084932 | 1.76 | 66.3 | null | 2019-08-07 | 2019-08-08 | Enzalutamide | null | Y | CETUXIMAB | 100157599 |
| 20224512 | 20084933 | 1.82 | 55.3 | Neo-adjuvant (N) | 2018-03-17 | 2018-03-19 | Enzalutamide | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101619688 |
| 20224522 | 20084934 | 1.51 | 72.8 | Palliative (P) | 2016-01-31 | 2016-02-04 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101640486 |
| 20224536 | 20084935 | 1.65 | 57 | Palliative (P) | 2019-03-18 | 2019-03-24 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100185429 |
| 20224541 | 20084936 | 1.86 | 102 | Palliative (P) | 2019-03-07 | 2019-03-07 | Enzalutamide | 02 | N | CISPLATIN | 100664140 |
| 20224548 | 20084937 | 1.82 | 64.2 | Adjuvant (A) | 2019-01-12 | 2019-01-12 | Mitomycin Intravesical | N | n | MITOMYCIN INTRAVESICULAR | 100282699 |
| 20224549 | 20084938 | 1.84 | 86.9 | Neo-adjuvant (N) | 2016-07-14 | 2016-07-15 | Capecitabine + Cisplatin + RT | N | Y | CAPECITABINE + CISPLATIN + RT | 100963001 |
| 20224550 | 20084939 | 1.7 | 54 | Palliative (P) | 2017-01-06 | 2017-01-20 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101080483 |
| 20224552 | 20084940 | 1.7 | 78 | Curative (C) | 2018-08-22 | 2018-08-30 | Enzalutamide | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100841667 |
| 20224555 | 20084941 | 1.75 | 93.7 | Palliative (P) | 2019-03-03 | 2019-03-04 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101795463 |
| 20224563 | 20084942 | 1.8 | 75.2 | null | 2016-08-06 | 2016-08-07 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + RT | 100753901 |
| 20224565 | 20084943 | 1.65 | 66.4 | null | 2019-02-11 | 2019-02-18 | Enzalutamide | 02 | null | ENZALUTAMIDE | 101400475 |
| 20224576 | 20084944 | 1.78 | 65 | Palliative (P) | 2017-07-26 | 2017-08-03 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101764002 |
| 20224578 | 20084945 | 1.8 | 98.7 | null | 2017-01-07 | 2017-01-07 | Enzalutamide | 02 | null | CISPLATIN | 100549436 |
| 20224593 | 20084946 | 1.83 | 60.7 | Palliative (P) | 2018-08-15 | 2018-08-21 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101051379 |
| 20224601 | 20084947 | 1.55 | 84 | null | 2017-02-09 | 2017-03-06 | CARBOPLATIN + PACLITAXEL + RT | N | null | CARBOPLATIN + PACLITAXEL + RT | 101832399 |
| 20224603 | 20084948 | 1.7 | 69.5 | Palliative (P) | 2015-03-07 | 2015-03-07 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100326799 |
| 20224604 | 20084949 | 1.55 | 54.5 | Neo-adjuvant (N) | 2019-11-01 | 2019-11-02 | Enzalutamide | 02 | N | CISPLATIN | 101092963 |
| 20224610 | 20084950 | 0 | 0 | Curative (C) | 2018-03-11 | 2018-03-12 | Enzalutamide | 02 | N | TRASTUZUMAB | 100824867 |
| 20224612 | 20084951 | 1.55 | null | null | 2019-10-10 | 2019-10-10 | Enzalutamide | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101384840 |
| 20224613 | 20084952 | 1.65 | 49.8 | Palliative (P) | 2017-08-03 | 2017-09-08 | Enzalutamide | 02 | N | TRASTUZUMAB | 101151415 |
| 20224623 | 20084953 | 0 | 0 | Palliative (P) | 2018-02-03 | 2018-02-07 | Enzalutamide | N | N | SCALOP-2 TRIAL | 100624162 |
| 20224627 | 20084954 | 1.59 | 51 | null | 2021-06-18 | 2021-07-15 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 100525651 |
| 20224629 | 20084955 | 1.57 | 63.6 | null | 2017-11-22 | 2017-12-08 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100442316 |
| 20224633 | 20084956 | 1.83 | 77.9 | Palliative (P) | 2019-10-11 | 2019-10-11 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100056267 |
| 20224643 | 20084957 | 1.51 | 77.4 | 03 | 2019-04-30 | 2019-05-07 | Capecitabine + Cisplatin + RT | 2 | N | CAPECITABINE + CISPLATIN + RT | 100834331 |
| 20224644 | 20084958 | null | 66 | Palliative (P) | 2016-07-02 | 2016-07-11 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100065738 |
| 20224646 | 20084959 | 0 | 0 | 03 | 2017-05-05 | 2017-05-05 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100769509 |
| 20224647 | 20084960 | 1.59 | 56 | Palliative (P) | 2017-01-29 | 2017-01-29 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101623804 |
| 20224650 | 20084961 | 1.8 | 60.7 | null | 2019-05-06 | 2019-05-23 | Enzalutamide | 02 | null | CETUXIMAB | 101407602 |
| 20224653 | 20084962 | 1.77 | 62.2 | Palliative (P) | 2019-01-20 | 2019-02-07 | Carboplatin AUC 2 - 5 | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100633752 |
| 20224654 | 20084963 | 1.77 | 65.4 | Palliative (P) | 2019-09-24 | 2019-09-24 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101353369 |
| 20224670 | 20084964 | 1.59 | 77 | Palliative (P) | 2017-08-06 | 2017-08-24 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100834290 |
| 20224671 | 20084965 | 1.62 | 68.4 | Curative (C) | 2017-06-05 | 2017-06-11 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100332801 |
| 20224673 | 20084966 | 1.69 | 59.8 | Palliative (P) | 2018-06-25 | 2018-07-18 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101653860 |